
Cardiologist

No OPD information available
Heart Failure
Hypertension
Heart Attack
Heart Failure with Preserved Ejection Fraction (HFpEF)
High Potassium Level
Renovascular Hypertension
Acute Arterial Occlusion of Kidney
Atherosclerosis
Atrial Fibrillation
Cardiac Ablation
Cardiac Arrest
Cardiomyopathy
Chronic Kidney Disease
Coronary Heart Disease
Diabetic Nephropathy
Endomyocardial Fibrosis
Low Blood Pressure
Low Potassium Level
Nephrectomy
Stroke
Type 2 Diabetes (T2D)
Wilson Disease
Henry Krum is a male healthcare provider who helps people with various heart and kidney problems like heart failure, high blood pressure, heart attacks, and more. He is skilled in treating conditions such as atrial fibrillation, diabetes, and stroke. He also stays updated on the latest medical knowledge and research to provide the best care for his patients.
Henry Krum communicates well with his patients, making them feel comfortable and confident in his care. Patients trust him because he listens to their concerns and explains things in a way they can understand. He is known for his compassionate and caring approach to healthcare.
In addition to working with patients, Henry Krum collaborates with other medical professionals to ensure the best outcomes for his patients. He values teamwork and respects his colleagues, which helps in providing comprehensive care to those in need.
Henry Krum's work has had a positive impact on many patients' lives. Through his expertise and dedication, he has helped improve the health and well-being of those he treats. His research on heart failure risk factors and participation in clinical trials like the Beta 3 Agonist Treatment in Heart Failure have contributed to advancements in medical care.
Overall, Henry Krum is a dedicated healthcare provider who goes above and beyond to help his patients lead healthier lives. His commitment to staying informed, his compassionate patient care, and his collaborative approach with colleagues make him a respected and trusted professional in the medical field.
Enrollment Status: Completed
Published: October 19, 2020
Intervention Type: Drug
Study Drug:
Study Phase: Phase 2
